1.

Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands

1.

Response: Re: Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands

1.

Response Re: Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands

1.

The management of cervical intra-epithelial neoplasia (CIN): Extensiveness and costs in The Netherlands

1.

Low risk of cervical cancer during a long period after negative screening in the Netherlands

2.

Low risk of cervical cancer during a long period after negative screening in the Netherlands

3.

Low risk of cervical cancer during a long period after negative screening in the Netherlands

1.

Regional differences in mortality from conditions amenable to medical intervention in The Netherlands: a comparison of four time periods.

2.

Regional differences in mortality from conditions amenable to medical intervention in The Netherlands: a comparison of four time periods.

3.

Regional differences in mortality from conditions amenable to medical intervention in The Netherlands: a comparison of four time periods.

1.

Response Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.

1.

Cervical cancer screening in the United States and the Netherlands: A tale of two countries

1.

Regional Differences in Decline of Mortality from Selected Conditions: The Netherlands, 1969-1984

1.

Cost of care of patients with cystic fibrosis in The Netherlands in 1990-1.

2.

Cost of care of patients with cystic fibrosis in The Netherlands in 1990-1.

3.

Cost of care of patients with cystic fibrosis in The Netherlands in 1990-1.